School of Medicine

An $18 million research program headed by Washington University School of Medicine in St. Louis will research therapies and diagnostic tools that use nanotechnology to treat heart and lung diseases.

Family members and close friends are more sensitive to early signs of Alzheimer’s dementia than traditional screening tests, according to researchers at Washington University School of Medicine in St. Louis.

Women in science and medicine were the focus of the Spotlight on Women in Medicine and Science (SWIMS) symposium Sept. 22 at the School of Medicine.

An innovative procedure that can replace a diseased heart valve is effective for patients who are too frail to endure open-heart surgery, according to results of a nationwide clinical study.

A Washington University scientist has been working with the federal government to determine what makes heart disease disabling. To determine cardiac disability, the committee recommended more functional testing and also discussed the need to evaluate not only a patient’s heart but the patient’s mood as well because depression can make heart disease worse. 

Washington University Frontiers in Technology and Science, a one-day conference modeled on the Kavli Frontiers of Science conference, hopes to connect WUSTL faculty in the sciences, engineering or mathematics and spur cross-disciplinary collaborations. The conference will be held from 10:30 a.m.-4:30 p.m. Saturday, Sept. 25, in Cupples I, Room 199.

A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well controlled on low doses of inhaled corticosteroids, says a new study.

A strong work ethic and the importance of family has fueled Terrie E. Inder’s  passion for determining the impact of premature birth on brain injury and development in the Neonatal Intensive Care Unit at St. Louis Children’s Hospital.

A search is under way to fill a new vice provost position in the Office of the Provost whose initial focus will be on diversity and faculty development, among other areas of university-wide importance. An advisory committee has been formed that will identify and recommend candidates from within the Washington University community.

An international team of Alzheimer’s disease experts, led by Washington University School of Medicine in St. Louis, has uncovered a gene variation that appears to predict the rate at which Alzheimer’s disease will progress. Whereas previous studies have focused on factors that influence the risk for developing Alzheimer’s, the new research points to a way to determine how rapidly the disease will progress.